Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Multipurpose prevention technologies for the prevention of unintended pregnancy, HIV, and other sexually transmitted infections: regulatory pathways and challenges.

PMID: 40433453 ·

L, o, g, a, n, , D, o, n, a, l, d, s, o, n, ;, , R, o, b, i, n, , S, c, h, a, e, f, e, r, ;, , S, a, r, a, h, , A, l, h, a, k, i, m, i, ;, , R, u, t, h, , A, k, u, l, u, ;, , T, h, e, s, l, a, , P, a, l, a, n, e, e, -, P, h, i, l, l, i, p, s, ;, , B, e, t, h, a, n, y, , Y, o, u, n, g, , H, o, l, t, ;, , V, e, r, o, n, i, c, a, , M, i, l, l, e, r

RevistaFrontiers in reproductive health
Ano
PMID40433453

Resumo

Multipurpose prevention technologies (MPTs) are multi-indication products commonly focusing on the prevention of unintended pregnancy, HIV, and/or other sexually transmitted infections (STIs). MPTs have the potential to simplify product use and service delivery with reduced clinic visits, thus supporting improved product uptake, effective use, and cost-effectiveness. MPTs are complex products that typically include multiple active pharmaceutical ingredients (APIs), with two or more indications,

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑